Accellacare

Executive Summary

Accellacare, a clinical research site network and services organization headquartered in Winston-Salem, North Carolina, operates as part of ICON plc's global clinical research network. Founded in 2018, the company is dedicated to delivering patient-centric clinical trial experiences through its network of research sites and in-home service capabilities. By focusing on improving patient recruitment and retention, Accellacare aims to provide sponsors with positive clinical research experiences that accelerate trial timelines and enhance data quality. Its integration within ICON plc provides access to extensive resources, operational expertise, and a global footprint, positioning the company to capitalize on the growing demand for decentralized and hybrid clinical trials. Accellacare's competitive advantage lies in its patient-first approach and the ability to offer flexible trial solutions, including home-based services that reduce participant burden. The clinical research industry is increasingly shifting toward patient-centric models, and Accellacare is well-positioned to benefit from this trend. As a subsidiary of a major CRO, the company benefits from ICON's scale and client relationships, while maintaining a focused operational model. Near-term growth is expected to be driven by expansion of its site network, adoption of digital health tools for remote monitoring, and strategic collaborations with biopharma sponsors seeking to improve trial diversity and efficiency. However, its performance is closely tied to ICON's overall strategy, which introduces some dependency risk.

Upcoming Catalysts (preview)

• Q4 2026Expansion of research site network and in-home service capabilities70% success
• Q1 2027Adoption of decentralized clinical trial technologies and partnerships60% success
• Q3 2026Strategic collaboration with ICON plc to secure large-sponsor contracts75% success